Alseres Pharmaceuticals, Inc. (ALSE) Stock Analysis
DELISTED
What happened to Alseres Pharmaceuticals, Inc. (ALSE) stock?
Alseres Pharmaceuticals, Inc. (ALSE) no longer trades on public markets. The figures below are historical and are not a current quote.
- Status:
- Delisted — no longer trades
For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Alseres Pharmaceuticals, Inc. (ALSE). Alseres Pharmaceuticals, Inc. is a biotechnology company focused on developing diagnostic and therapeutic products for central nervous system disorders. Its primary product candidate, Altropane, is an imaging agent for Parkinson's disease and dementia diagnosis.
Last analyzed: Jun 15, 2026Alseres Pharmaceuticals, Inc. (ALSE) Healthcare & Pipeline Overview
ALSE OTC Market Information
ALSE trades on the OTC Other market tier of OTC Markets.
- OTC Tier: OTC Other
More about this archive record
Can I still buy ALSE shares?
No. ALSE stopped trading on public markets, so the shares are not available through a broker. Anything you see quoted for ALSE elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before ALSE stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to Alseres Pharmaceuticals, Inc.. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.